Evaluation of a 5-day High-Dose Course of Amoxicillin for the Management of Community-Acquired Pneumonia in Children of 6 months to 10 years of Age

J Pediatric Infect Dis Soc. 2022 Dec 5;11(11):480-481. doi: 10.1093/jpids/piac025.
No abstract available

MeSH terms

  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Community-Acquired Infections* / drug therapy
  • Humans
  • Infant
  • Pneumonia* / drug therapy

Substances

  • Amoxicillin
  • Anti-Bacterial Agents